FDA
-
-
-
-
-
-
-
AstraZeneca IMFINZI combo cuts liver cancer progression risk by 30%
-
-
-
-
-
-
-
Daiichi Sankyo gets US approval for Datroway in metastatic breast cancer
-
-
-
-
-
-
-
BAXFENDY approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension
-
-
-
-
-
-
-
FDA Panel Votes 6-3 'no' On Astrazeneca Breast Cancer Drug
-
-
-
-
-
-
-
FDA approves multiple generics of Farxiga
-
-
-
-
-
-
-
AstraZeneca's CALQUENCE plus venetoclax wins FDA approval for CLL treatment
-
-
-
-
-
-
-
DATROWAY® Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy
-
328,092 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

